CD63 and neoplasm: Subsequently, we also revealed the colocalization of PD-L1 with CD63, a marker protein of sEVs, by immunofluorescence staining in tumour cells and found that it was promoted after the treatment with aT-sEVs (Fig. 4g), suggesting the enhanced secretion of PD-L1 via sEVs.